3T Biosciences Announces Appointment of John Leonard, M.D. to its Board of Directors
- Tuesday, October 25, 2022, 7:12
- PR Newswire
- Add a comment
Current president and CEO of Intellia Therapeutics and previous global head of Abbvie’s R&D brings more than 30 years’ experience leading discovery, development, and launch of groundbreaking blockbuster medicines SAN FRANCISCO, Calif., Oct. 25, 2022 /PRNewswire/ — 3T Biosciences (“3T”),…